Lyft, Inc. (LYFT)

Theseus Pharmaceuticals Stock Forecast

Stock Price Forecast

The 30 analysts that cover Theseus Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $16.82, which forecasts a 23.49% increase in the stock price over the next year. The lowest target is $10 and the highest is $28.

Price Target: $16.82 (+23.49%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$10	$16.82	$16	$28
Change	-26.58%	+23.49%	+17.47%	+105.58%

Analyst Ratings

The average analyst rating for Theseus Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	6	5	5	5	6	6
Buy	3	3	3	4	3	4
Hold	25	26	26	25	24	23
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	34	34	34	34	33	33

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Stephen Ju UBS	UBS	Hold Maintains $14 → $15	Hold	Maintains	$14 → $15	+10.13%	Jul 29, 2025
Nikhil Devnani Bernstein	Bernstein	Hold Maintains $16 → $18	Hold	Maintains	$16 → $18	+32.16%	Jul 21, 2025
Chad Larkin Oppenheimer	Oppenheimer	Buy Maintains $17 → $20	Buy	Maintains	$17 → $20	+46.84%	Jul 8, 2025
Ken Gawrelski Wells Fargo	Wells Fargo	Hold Maintains $13 → $14	Hold	Maintains	$13 → $14	+2.79%	Jul 7, 2025
George Gianarikas Canaccord Genuity	Canaccord Genuity	Strong Buy → Hold Downgrades $22 → $14	Strong Buy → Hold	Downgrades	$22 → $14	+2.79%	Jun 27, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

6.59B

Increased by 13.91%

from 5.79B

Revenue Next Year

7.45B

Increased by 12.99%

from 6.59B

EPS This Year

0.20

Increased by 253.38%

from 0.06

EPS Next Year

0.46

Increased by 133.37%

from 0.20

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	2.36B	3.21B	4.10B	4.40B	5.79B	6.59B	7.45B	8.30B
Revenue Growth	-34.60%	35.68%	27.64%	7.53%	31.39%	13.91%	12.99%	11.39%
EPS	-5.61	-3.17	-4.47	-0.88	0.06	0.20	0.46	0.78
EPS Growth	-	-	-	-	-	253.38%	133.37%	70.53%
Forward PE	-	-	-	-	-	69.22	29.66	17.39
No. Analysts	-	-	-	-	-	46	46	29

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	7.0B	8.9B	9.2B
Avg	6.6B	7.4B	8.3B
Low	5.8B	6.2B	6.8B

Revenue Growth

Revenue Growth	2025	2026	2027
High	20.4%	35.5%	23.5%
Avg	13.9%	13.0%	11.4%
Low	0.9%	-6.3%	-8.2%

EPS Forecast

EPS	2025	2026	2027	2028
High	0.42	0.90	1.92
Avg	0.20	0.46	0.78
Low	-0.17	-0.09	0.09

EPS Growth

EPS Growth	2025	2026	2027	2028
High	654.3%	358.9%	318.5%
Avg	253.4%	133.4%	70.5%
Low	-	-	-80.8%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.